Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Full Circle: David Hung Looks Forward To Axovant's Alzheimer's Data, Reflects On Medivation

Executive Summary

As the CEO of Axovant, David Hung is back where he started with Medivation – working on a drug for Alzheimer's disease.

Advertisement

Related Content

Hung Out As Axovant Rebuilds Its Pipeline, Expands Focus Beyond Dementia
Finance Watch: Roivant Raises $1.1bn, Relying On Private Equity To Fund New Companies
Pfizer/Astellas Amend Trial To Position Xtandi In Early Prostate Cancer
Janssen's Zytiga Shines At ASCO But Prostate Cancer Pipeline Progress May Dampen Impact
Xtandi Sales Disappoint Pfizer, Returning Focus To The High-Priced Deal
Appointments: Sanofi, Recipharm, Axovant, e-Therapeutics & Diplomat
Can Axovant's RVT-1 Redeem 5HT6 Class After Lundbeck's Idalopirdine Failure?
Pfizer’s $14bn Medivation Buyout Shows How Far Pharma Will Go In Oncology
Medivation Rejects Sanofi's Latest Bid, But Enters Confidential Negotiations
New Xtandi data bolster case for pre-chemo use

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC099023

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel